PRINTER'S NO. 2459
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE RESOLUTION
No.
483
Session of
2019
INTRODUCED BY O'NEAL, ORTITAY, OWLETT, PYLE, PICKETT, DONATUCCI,
DUNBAR, BURNS, OTTEN, MILLARD, MURT, LONGIETTI, DiGIROLAMO,
YOUNGBLOOD, READSHAW, SAYLOR, DEASY, DeLUCA AND HILL-EVANS,
SEPTEMBER 16, 2019
REFERRED TO COMMITTEE ON HEALTH, SEPTEMBER 16, 2019
A RESOLUTION
Urging the Congress of the United States to direct the National
Institutes of Health to conduct a comprehensive study on the
causes of Ewing sarcoma.
WHEREAS, Ewing sarcoma is a cancerous tumor that occurs in
bones or soft tissue, such as cartilage or nerves; and
WHEREAS, Ewing sarcoma is the second most common primary bone
tumor in children and accounts for approximately 1% of all
childhood cancer diagnoses; and
WHEREAS, There are several types of Ewing sarcoma, including
Ewing sarcoma of bone, extraosseous Ewing sarcoma, peripheral
primitive neuroectodermal tumor and Askin tumor; and
WHEREAS, It is estimated that 200 children are diagnosed with
one of these types of tumors each year in the United States; and
WHEREAS, From 2008 to 2017, there were 306 diagnosed Ewing's
Family of Tumors cases in this Commonwealth; and
WHEREAS, Symptoms of Ewing sarcoma may include pain in the
bone where the tumor is located, swelling in the area of the
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17